" class="no-js "lang="en-US"> Lord Bethell Archives - Medtech Alert
Saturday, December 09, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives

Thousands of lives will be saved thanks to more blood pressure checks in high street […]

MHRA Puts Delivering for Patients at the Heart of its Delivery Plan 2021-2023

A new and ambitious Delivery Plan centred on putting patients first, has been published today […]

£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery

Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]

Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics

Life science industry leaders are joining forces with governments to step up collective efforts to […]

Study into Whether Vaccination of Previously Infected Generates Stronger, Broader Coronavirus Antibody Response

NHS Blood and Transplant (NHSBT) is carrying out a study in the Birmingham region aimed […]

Vaccine Status Drives Over One Million New Users to the NHS App

Over 1.3 million new people have registered to use the NHS App since the addition […]

NHSBT: First Blood Plasma for Medicines Donations Begin

NHS Blood and Transplant (NHSBT) will from today take donations at 14 donor centres around […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more